MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

Cancer

Volumn 117, Issue 8, 2011, Pages 1630-1639

  Patterson, Erin E ^a   Holloway, Alisha K ^b   Weng, Julie ^c   Fojo, Tito ^a,c   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GLADSTONE INSTITUTES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adrenal; adrenocortical carcinoma; diagnostic marker; microRNA

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 125B; MICRORNA 195; MICRORNA 483; MOLECULAR MARKER; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADRENAL CORTEX NEOPLASMS; EUKARYOTIC INITIATION FACTOR-3; GENE EXPRESSION PROFILING; INSULIN-LIKE GROWTH FACTOR II; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VALIDATION STUDIES AS TOPIC;

EID: 79953767181     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25724     Document Type: Article

References (39)

1. Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg. 2001; 25: 891-897. (Pubitemid 32666390)
2. Favia G, Lumachi F, Carraro P, D'Amico DF., Adrenocortical carcinoma. Our experience. Minerva Endocrinol. 1995; 20: 95-99.
3. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000; 88: 711-736. (Pubitemid 30091090)
4. Brunt LM, Moley JF., Adrenal incidentaloma. World J Surg. 2001; 25: 905-913. (Pubitemid 32666393)
5. Lau SK, Weiss LM., The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol. 2009; 40: 757-768.
6. He L, Hannon GJ., MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5: 522-531. (Pubitemid 38868508)
7. Fernandez-Ranvier GG, Weng J, Yeh RF, et al. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg. 2008; 143: 841-846; discussion 846.
8. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5: R80.
9. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002; 30: e15.
10. Smyth GK, Speed T., Normalization of cDNA microarray data. Methods. 2003; 31: 265-273. (Pubitemid 37338763)
11. Smyth GK., Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3: Article3.
12. Smyth GK,. Limma: Linear Models for Microarray Data. In:, Robert Gentleman VJC, Wolfgang Huber, Rafael A,. Irizarry and Sandrine Dudoit, ed. Bioinformatics and Computational Biology Solutions Using R and Bioconductor, vol. V. New York: Springer, 2005: 397-420.
13. Benjamini Y, Hochberg Y., Controlling the False Discovery Rateâa Practical and Powerful Approach to Multiple Testing. JR Stat Soc Ser B Methodol. 1995; 57: 289-300.
14. Andersen CL, Jensen JL, Orntoft TF., Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64: 5245-5250. (Pubitemid 39006544)
15. Shi W, Alajez NM, Bastianutto C, et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer. 2010; 126: 2036-2048.
16. Stephan EA, Chung TH, Grant CS, et al. Adrenocortical carcinoma survival rates correlated to genomic copy number variants. Mol Cancer Ther. 2008; 7: 425-431. (Pubitemid 351302536)
17. Kjellman M, Kallioniemi OP, Karhu R, et al. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. Cancer Res. 1996; 56: 4219-4223. (Pubitemid 26305019)
18. Zhao J, Speel EJ, Muletta-Feurer S, et al. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis. Am J Pathol. 1999; 155: 1039-1045. (Pubitemid 29488910)
19. Sidhu S, Marsh DJ, Theodosopoulos G, et al. Comparative genomic hybridization analysis of adrenocortical tumors. J Clin Endocrinol Metab. 2002; 87: 3467-3474. (Pubitemid 34816405)
20. Soon PS, Libe R, Benn DE, et al. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors. Ann Surg. 2008; 247: 157-164.
21. Osaki M, Takeshita F, Ochiya T., MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers. 2008; 13: 658-670.
22. DeChiara TM, Robertson EJ, Efstratiadis A., Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991; 64: 849-859. (Pubitemid 121001171)
23. Giordano TJ, Thomas DG, Kuick R, et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol. 2003; 162: 521-531. (Pubitemid 36267859)
24. de Fraipont F, El Atifi M, Cherradi N, et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab. 2005; 90: 1819-1829. (Pubitemid 40464057)
25. Velazquez-Fernandez D, Laurell C, Geli J, et al. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery. 2005; 138: 1087-1094. (Pubitemid 41797349)
26. Slater EP, Diehl SM, Langer P, et al. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors. Eur J Endocrinol. 2006; 154: 587-598.
27. de Reynies A, Assie G, Rickman DS, et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol. 2009; 27: 1108-1115.
28. Giordano TJ, Kuick R, Else T, et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin Cancer Res. 2009; 15: 668-676.
29. Soon PS, Gill AJ, Benn DE, et al. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr Relat Cancer. 2009; 16: 573-583.
30. Soon PS, Tacon LJ, Gill AJ, et al. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res. 2009; 15: 7684-7692.
31. Veronese A, Lupini L, Consiglio J, et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res. 2010; 70: 3140-3149.
32. Meyer-Rochow GY, Jackson NE, Conaglen JV, et al. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer. 2010; 17: 835-846.
33. Almeida MQ, Fragoso MC, Lotfi CF, et al. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J Clin Endocrinol Metab. 2008; 93: 3524-3531.
34. Barlaskar FM, Spalding AC, Heaton JH, et al. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metab. 2009; 94: 204-212.
35. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513-10518.
36. Garzon R, Calin GA, Croce CM., MicroRNAs in Cancer. Annu Rev Med. 2009; 60: 167-179.
37. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM., MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. HEPATOLOGY. 2009; 50: 113-121.
38. Iliopoulos D, Bimpaki EI, Nesterova M, Stratakis CA., MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling. Cancer Res. 2009; 69: 3278-3282.
39. Doghman M, El Wakil A, Cardinaud B, et al. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res.; 70: 4666-4675.